CClinicalTrials.gg
CompletedNCT01869595Updated Nov 25, 2024

Thai MSM/TG Test and Treat Study

An observational study in HIV Testing Rate and Acceptance of Immediate ART, sponsored by Thai Red Cross AIDS Research Centre. Completed at 1 site in Thailand. Open to male participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-25.

Sponsored by Thai Red Cross AIDS Research Centre · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
18 Years to 90 Years
Sex
Male
01

Study summary

Objectives

  1. To determine the uptake of universal HIV testing among Thai men who have sex with men (MSM) and transgender women (TG)
  2. To determine the uptake of antiretroviral treatment (ART) regardless of CD4 count among Thai MSM/TG who test positive for HIV

Subject population:. Men or transgender women who have sex with men,Thai nationals, age ≥18 years old, Have engaged in anal intercourse with a man without using a condom at least one time in the last 6 months or have had at least 3 male sex partners in the last 6 months,Not known to be HIV-positive (either have never been tested for HIV or have had a previous negative HIV test)

Number of participants:2000 Thai MSM and TG with approximately 76%-90% in Bangkok, 5%-12% in Lampang and 5-12% in Ubonratchathani.

Read the detailed description

All participants will receive HIV testing at baseline. The frequency of study visits to determine HIV status in HIV-negative participants will be every 6 months for a total follow up time of 24 months. Once HIV-positive status is confirmed, participants will be offered ART immediately regardless of CD4 count. Those who accept ART will be seen more frequently following ART initiation, at 2 weeks, 4 weeks, 2 months, 3 months and every 3 months thereafter until completion of 24 months of follow-up. Those who deny immediate ART will have clinic visits every 6 months to monitor HIV disease. HIV-negative participants will be asked to come for HIV re-testing every 6 months or sooner if they feel exposed to risk

02

Conditions studied

  • HIV Testing Rate
  • Acceptance of Immediate ART

Keywords

  • 2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani
03

In context

Lead sponsor

Thai Red Cross AIDS Research Centre is the lead sponsor of 30 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

men who have sex with men and transgender women in Thailand

Inclusion criteria

  1. Thai nationals
  2. Age >18 years
  3. Men or transgender women who have sex with men
  4. Have engaged in anal intercourse with a man without using a condom at least one time in the last 6 months or have had at least 3 male sex partners in the last 6 months
  5. Not known to be HIV-positive (either have never been tested for HIV or have had a previous negative HIV test)
  6. Have signed the consent form

Exclusion criteria

Exclusion Criteria:

  1. Known HIV-positive serostatus
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (actual)
Target follow-up
2 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Primary endpoints

    * Proportion of MSM who present for testing who have not previously had an HIV test * Proportion of HIV-negative participants who have HIV re-testing over the study period * Proportion of HIV-positive participants who accept ART regardless of CD4 count

    Time frame: December 1, 2015

07

Study locations

1 site
  • The Thai Red Cross AIDS Research Centre
    Pathum Wan, Bangkok 10330, Thailand
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01869595
Lead sponsor
Thai Red Cross AIDS Research Centre
Collaborators
National Research Council of Thailand, Ministry of Health, Thailand, The Government Pharmaceutical Organization, National Health Security Office, Thailand
Responsible party
Sponsor
First posted
Jun 5, 2013
Start date
Nov 2012
Primary completion
Dec 2019
Completion
Nov 2020
Last update
Nov 25, 2024

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion